Orchestra BioMed Holdings, Inc. Increase (Decrease) in Inventories
Orchestra BioMed Holdings, Inc. (OBIO) reported Increase (Decrease) in Inventories of -$60.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-10
- Orchestra BioMed Holdings, Inc. increase (decrease) in inventories for the quarter ending 2026-06-30 was -$27.00K, a 155.10% decline year-over-year.
- Orchestra BioMed Holdings, Inc. increase (decrease) in inventories for the quarter ending 2026-03-31 was -$33.00K.
- Orchestra BioMed Holdings, Inc. increase (decrease) in inventories for the quarter ending 2025-12-31 was -$55.00K.
- Orchestra BioMed Holdings, Inc. increase (decrease) in inventories for the quarter ending 2025-09-30 was $181.00K, a 10.37% increase year-over-year.
- Orchestra BioMed Holdings, Inc. increase (decrease) in inventories for fiscal 2025 was $137.00K, a 389.29% increase from fiscal 2024.
- Orchestra BioMed Holdings, Inc. increase (decrease) in inventories for fiscal 2024 was $28.00K.
- Orchestra BioMed Holdings, Inc. increase (decrease) in inventories for fiscal 2023 was -$131.00K, a 162.98% decline from fiscal 2022.
- Orchestra BioMed Holdings, Inc. increase (decrease) in inventories for fiscal 2022 was $208.00K.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$60.00K 10-Q · filed 2026-08-10 | -$115.00K derived: sum of 3 quarters · filed 2026-08-10 | $66.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$33.00K 10-Q · filed 2026-05-12 | -$88.00K derived: sum of 2 quarters · filed 2026-05-12 | $93.00K derived: sum of 3 quarters · filed 2026-05-12 | $142.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $126.00K derived: sum of 2 quarters · filed 2026-03-12 | $175.00K derived: sum of 3 quarters · filed 2026-08-10 | $137.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $181.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $230.00K derived: sum of 2 quarters · filed 2026-08-10 | $192.00K 10-Q · filed 2025-11-10 | $132.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $49.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $11.00K 10-Q · filed 2026-08-10 | -$49.00K derived: sum of 3 quarters · filed 2026-08-10 | $115.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$38.00K 10-Q · filed 2026-05-12 | -$98.00K derived: sum of 2 quarters · filed 2026-05-12 | $66.00K derived: sum of 3 quarters · filed 2026-05-12 | $21.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $104.00K derived: sum of 2 quarters · filed 2026-03-12 | $59.00K derived: sum of 3 quarters · filed 2026-03-12 | $28.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $164.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $119.00K derived: sum of 2 quarters · filed 2025-11-10 | $88.00K 10-Q · filed 2025-11-10 | $96.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$76.00K 10-Q · filed 2025-08-12 | -$68.00K derived: sum of 3 quarters · filed 2025-08-12 | -$109.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$31.00K 10-Q · filed 2025-05-12 | -$23.00K derived: sum of 2 quarters · filed 2025-05-12 | -$64.00K derived: sum of 3 quarters · filed 2025-05-12 | -$118.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$33.00K derived: sum of 2 quarters · filed 2025-03-31 | -$87.00K derived: sum of 3 quarters · filed 2025-03-31 | -$131.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | -$41.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$95.00K derived: sum of 2 quarters · filed 2024-11-12 | -$139.00K 10-Q · filed 2024-11-12 | -$193.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$54.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$98.00K 10-Q · filed 2024-08-12 | -$152.00K derived: sum of 3 quarters · filed 2024-08-12 | $45.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | -$44.00K 10-Q · filed 2024-05-13 | -$98.00K derived: sum of 2 quarters · filed 2024-05-13 | $99.00K derived: sum of 3 quarters · filed 2024-05-13 | $200.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $143.00K derived: sum of 2 quarters · filed 2024-03-27 | $244.00K derived: sum of 3 quarters · filed 2024-03-27 | $208.00K 10-K · filed 2024-03-27 |
| 2022-09-30 | $197.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $298.00K derived: sum of 2 quarters · filed 2023-11-13 | $262.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $101.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $65.00K 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | -$36.00K 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |